Prof Mark Sullivan

Mark SullivanProf Mark Sullivan

MD FRCS (Urol)
GMC number: 3338812
Year of qualification: 1989

Areas of expertise:

General Urology, Haematuria, Kidney Surgery, Renal Cancer, Urological Cancer, Robotic Surgery, Andrology, Penile corrective surgery, vasectomy reversal

  • Day and time – Nuffield Hospital – The Manor, Oxford
Member of:
  • Royal College of Surgeons of Edinburgh (Fellow)
  • British Association of Urological Surgeons
  • European Association of Urology
  • EAU Robotic Urology Section
Contact details:

Tel: 01865- 307733

Subspecialty services that this consultant provides:

Prof Sullivan is a recognised leading national and international expert in the management of kidney cancer:

Areas of expertise:

Kidney Cancer
Laparoscopic kidney surgery
Robotic kidney surgery
Vasectomy and vasectomy reversal
Male fertility
Peyronie’s disease


Mark Sullivan is a Consultant Urological Surgeon and Associate Professor at the Oxford University Hospitals NHS Foundation Trust and University of Oxford respectively. In 2014, he was also appointed Clinical Director of the Renal, Transplant and Urology Directorate at the Oxford University Hospitals NHS Foundation Trust. He qualified from University College London in 1989, and trained in Surgery and Urology at Nottingham, Cambridge. London and Oxford.

Prof Sullivan is an international authority on renal cancer and leading UK surgeon offering open, laparoscopic and robotic options for treatment. He provides the renal autotransplantation service in Oxford, a nationally commissioned service, only available in Oxford, which has allowed a cohort of patients in the UK to have complex renal cancers excised from either solitary or both kidneys and thereby avoiding dialysis in most cases. He is also a national authority on erectile dysfunction and is happy to offer specialist advice and management to patients.


Mark’s research activities encompass clinical, translational and basic science programmes on the biology of renal cancer, with specific interests in the molecular mechanisms of disease  progression, disease response and novel minimally invasive treatments of small renal cancers (SRM’s). He also has research interests in mechanisms of erectile dysfunction. He has been on the NCRI Renal Cancer Studies group for 7 years and has been involved in a number of national clinical trials involving surgical and chemotherapy treatments for renal cancer.

Languages spoken:


Current posts:

Consultant Urological Surgeon, Oxford University Hospitals NHS Foundation Trust

Associate Professor in the Nuffield Department of Surgical Science, University of Oxford

Comments are closed.